AP-HP, Hôpital Tenon, Department of Dermatology, Paris, France.
Future Oncol. 2009 Nov;5(9):1441-8. doi: 10.2217/fon.09.111.
The influence of pregnancy on the occurrence and evolution of maternal tumors has been long debated. Breast carcinomas or melanomas have been suspected to be more severe during gestation. Recently, many investigators have described the transfer and persistence of fetal cells in maternal circulation and tissues during and after pregnancy. These fetal microchimeric cells have been described in a variety of maternal injured tissues where they displayed the host-tissue phenotype. Given the wide variety of injury and tissue types described, cancer has appeared as a potential situation that could be influenced by fetal microchimeric cells. This new unexplored effect of gestation on tumor course has been hypothesized as either protective against cancer, via the activity of allogenic fetal cells, or as promoting cancer, via a supportive role of fetal microchimeric cells in the tumor stroma. In this review, we will detail recent data supporting these hypotheses.
妊娠对母源性肿瘤的发生和发展的影响一直存在争议。有人怀疑妊娠期间乳腺癌或黑色素瘤更为严重。最近,许多研究人员描述了在妊娠期间和之后,胎儿细胞在母体循环和组织中的转移和持续存在。这些胎儿微嵌合细胞已在多种母体受损组织中被描述,在这些组织中,它们表现出宿主组织表型。鉴于所描述的损伤和组织类型多种多样,癌症似乎是一种可能受到胎儿微嵌合细胞影响的潜在情况。妊娠对肿瘤进程的这种新的未被探索的影响被假设为通过同种异体胎儿细胞的活性对癌症具有保护作用,或者通过胎儿微嵌合细胞在肿瘤基质中的支持作用促进癌症。在这篇综述中,我们将详细介绍支持这些假说的最新数据。